Christina E. Curtin

Genetic testing in endometrial cancer (GenEC): A study on the patient experience with MSK-IMPACT.

Christina E. Curtin, Nancy Varice, Varshini Gali, Gabrielle Bennetti et autres

e22635 Background: Guidelines recommend consideration of genetic testing (GT) for patients with endometrial cancer (EC); however, real-world uptake varies, and data are limited on the patient experience. We aimed to measure uptake of GT in EC and survey patient perspectives. Methods: All …

us (code pays fourni par la source)

Age at ovarian cancer diagnosis varies by lynch syndrome gene: A genetic testing laboratory registry study

Ying Liu, Christina E. Curtin, Alicia J. Latham, Kelsey E. Breen et autres

us (code pays fourni par la source)

ADC target expression in primary and matched recurrent high-grade endometrial carcinomas

Christina E. Curtin, Hunter Green, Nancy Varice, Amir Momeni Boroujeni et autres

us (code pays fourni par la source)

Multimodal predictors of recurrence in patients with germline BRCA1/2-associated ovarian cancer receiving frontline PARP inhibitor maintenance

Christina E. Curtin, Qin Zhou, Bree E. Martin, Nikita Mehta et autres

us (code pays fourni par la source)

Mutational landscape of endometrial carcinomas and their patient-derived xenografts

Christina E. Curtin, David Brown, Hunter Green, Nancy Varice et autres

us (code pays fourni par la source)

Uterine leiomyosarcoma progression: A study of serial recurrences

Tiffany Sia, David N. Brown, Kathryn Miller, Christina E. Curtin et autres

us (code pays fourni par la source)

Clinical-pathologic features and survival outcomes in women with uterine versus retroperitoneal leiomyosarcoma

Christina E. Curtin, William A. Zammarrelli, Effi Yeoshoua, Mario M. Leitão et autres

us (code pays fourni par la source)

1154P Evaluation of POLD1-mutated endometrial carcinomas

Christina E. Curtin, Paul M. Johannet, Ying Liu, J.J. Mueller et autres

us (code pays fourni par la source)

Breast cancer post-ovarian cancer in germline non-BRCA homologous recombination (HR) gene pathogenic variant carriers.

Ariadna Roqué, Yelena M. Kemel, Margaret R. Sheehan, Christina E. Curtin et autres

10607 Background: Ovarian cancer (OC) is characterized by deficiencies in homologous recombination (HR). Although germline and somatic BRCA1/2 pathogenic variants (PVs) play a critical role in HR and OC, germline PVs in other genes associated with HR, such as RAD51C, RAD51D, BRIP1 …

es, us (code pays fourni par la source)

34 Cancer survival in women diagnosed with leiomyosarcoma of the uterus

Christina E. Curtin, Donald D. McIntire, Jayanthi Sivasothy Lea

Black women with endometrial cancer have a disproportionately worse disease-specific survival and markedly higher mortality compared to white women. In addition, Black women are more likely to have uterine sarcomas compared to white women. The aim of this study was to examine …

us (code pays fourni par la source)

Risk Factors of Survival in Dedifferentiated Liposarcoma

Kevin Nguyen, Jonathan Gootee, Sarah Aurit, Sara Albagoush et autres

Background: Liposarcoma is the most common malignant soft tissue sarcoma for which surgical resection is the most utilized therapeutic option. In this study, we aimed to explore the associations of surgical margins among other risk factors on survival in patients with dedifferentiated …

us (code pays fourni par la source)

Prognostic Factors After Neoadjuvant Imatinib for Newly Diagnosed Primary Gastrointestinal Stromal Tumor

Michael J. Cavnar, Kenneth Seier, Mithat Gönen, Christina E. Curtin et autres

us (code pays fourni par la source)